To further ascertain the fusion of lysosome with autophagosome in GYZ-treated NSCLC cells, we evaluated the colocalization of LC3 with the lysosome marker, LAMP2. The gene discussed is MAP1LC3A; the disease is non-small cell lung carcinoma.